Drug & Gene Delivery Systems Market Size, Share, Growth Report 2030

Drug & Gene Delivery Systems Industry Perspective:

The drug & gene delivery systems market size is set for rapid growth over the forecast period. In terms of revenue, the global drug & gene delivery systems market accounted for USD 483.9 Billion in 2022 and is expected to reach USD 815.6 Billion by 2030, growing at a CAGR of 7.33% during the forecast period.

Request Free Sample

Drug & Gene Delivery Systems Market: Overview

Drugs are the first-line treatment for nearly any minor or significant disease. The definition of drugs derives from the word drug delivery systems, which can be used to be a mechanism or formulation used to introduce a medicinal agent into the body. This system or formulation helps improve the medication’s potency within the body. A typical example can be a nasal spray, majorly used by people with nasal congestion.

With an increasing number of diseases making their presence across the globe, in order to achieve the optimized desired response, organizations have succeeded, to a large degree, in developing various drug administration routes. The targeted method of drug delivery allows doctors to specifically target the area in the body that needs care, avoiding the surrounding areas. This prevents any adverse effects that could have arisen, while also ensuring that the medicine's efficacy is preserved at the target level. Factors such as reducing the amount of Active Pharmaceutical Ingredient (API) per dose and increasing patient comfort are targeted in the production of drug delivery systems.

On the other hand, gene delivery mechanisms include the introduction of foreign genetic materials, DNA or RNA, into the host cell. In order for gene transmission to be successful, these foreign genetic materials should remain stable in the host cell, be incorporated into the genome, or be duplicated independently.

Gene delivery is also important in crops’ genetic modification and applications in human therapeutics. A significant number of current clinical trials demonstrate the degree to which pharmaceutical companies are turning their attention to gene therapy. The demand for gene delivery systems is expected to be driven by the high potential of gene therapy and the production of successful vectors.

Key Insights

• As per the analysis shared by our research analyst, the global drug & gene delivery systems market is expected to grow annually at a promising CAGR of around 7.33% during the forecast period 2023-2030.
• In terms of revenue, the global drug & gene delivery systems market size was valued at around USD 483.9 billion in 2022 and is expected to reach USD 815.6 billion by 2030.
• The global drug and gene delivery systems market is primarily driven by the increasing prevalence of chronic diseases worldwide.
• Based on delivery system, the drug delivery system segment held the largest market share in 2022.
• Based on route of administration, the oral segment held the largest market share in 2022.
• Based on region, the North American region held the dominating market share in 2022.

Request Free Sample

Drug & Gene Delivery Systems Market: Growth Factors

Increase in the cases of chronic diseases among people across the globe to drive the industry growth

The global drug and gene delivery systems market is primarily driven by the increasing prevalence of chronic diseases worldwide. The rising incidence of conditions such as cancer, diabetes, and cardiovascular diseases has fueled the demand for advanced drug delivery systems that can improve treatment efficacy and reduce side effects. Additionally, advancements in nanotechnology have enabled the development of more targeted and personalized drug delivery solutions, further driving market growth. Moreover, the growing demand for non-invasive drug delivery methods, such as inhalation and transdermal delivery, has created new opportunities for drug and gene delivery systems manufacturers.

Drug & Gene Delivery Systems Market: Restraints

Extortionate costs of development and tedious regulatory approvals might hinder the growth of the industry to an extent

One of the key restraints facing the drug and gene delivery systems industry is the high cost of development and regulatory approval. The complex nature of drug delivery systems and the stringent regulatory requirements can significantly increase the time and cost of bringing new products to market. Another challenge is the lack of reimbursement for some drug delivery systems, particularly those that are considered experimental or innovative.

Drug & Gene Delivery Systems Market: Opportunities

Growing inclination toward personalized medicine creates ample opportunities for the industry

The drug and gene delivery systems market presents several opportunities for manufacturers and investors. One key opportunity is the rise in biologics development, which has created a need for innovative drug delivery systems that can improve the safety and efficacy of biologic drugs. Another opportunity is the increasing focus on personalized medicine, which has led to the development of new drug delivery systems that can be tailored to the needs of individual patients. Additionally, the growing demand for self-administered drug delivery systems and the rising adoption of digital health technologies are expected to create new growth opportunities in the market. Thus, the drug and gene delivery systems market is poised for continued growth and innovation in the coming years.

Drug & Gene Delivery Systems Market: Challenges

Lack of standardization in drug delivery systems might act as a challenge for the industry

The drug and gene delivery systems industry also faces several challenges that could impact future growth. One of the biggest challenges is the risk of adverse events associated with drug delivery systems, such as allergic reactions or infections. Another challenge is the need for better delivery technologies for certain types of drugs, such as those with poor solubility or stability. Additionally, the lack of standardization and compatibility between different drug delivery systems can pose challenges for healthcare providers and patients. Addressing these challenges will be crucial for driving continued innovation and growth in the drug and gene delivery systems market.

Drug & Gene Delivery Systems Market: Segmentation

The global drug and gene delivery systems market is segmented based on delivery system, route of administration, application, and region.

Based on delivery system, the market is segmented into drug delivery system and gene delivery system segments. The drug delivery system segment held the largest market share in 2022 and is predicted to grow at a remarkable CAGR during the forecast period. This growth can be attributed to several factors, including an increasing demand for targeted and personalized therapies, advancements in drug delivery technologies, and a rising prevalence of chronic diseases. Additionally, the growing trend towards the self-administration of drugs has increased demand for convenient and easy-to-use drug delivery systems, such as inhalers and transdermal patches. With the ongoing development of new drug delivery technologies and the continued focus on patient-centric healthcare, the drug delivery system segment is expected to continue its growth trajectory in the coming years.

Based on route of administration, the drug and gene delivery systems industry is segmented into oral, ocular, nasal, injectable, inhalation, transdermal, and topical. The oral segment held the largest market share in 2022 and is further predicted to grow rapidly at a significant CAGR during the forecast period. This growth can be attributed to several factors, including the convenience and ease of administration of oral drugs, the growing prevalence of chronic diseases that require long-term treatment, and the development of novel oral drug delivery technologies. Additionally, the rising demand for patient-centric healthcare and personalized medicine has led to an increase in the development of oral drugs with targeted and specialized delivery systems. With ongoing advancements in technology and a focus on improving patient outcomes, the oral segment of the drug delivery systems market is expected to continue its growth in the future.

Based on application, the market is segmented into Diabetes, Central Nervous System (CNS), Infectious Diseases, Oncology, and others.

Recent Developments

• In September 2021, Pfizer and BioNTech announced positive results from a Phase 2/3 trial of their COVID-19 vaccine in children aged 5 to 11 years. The vaccine was found to be safe and effective, with a lower dosage than that given to adults. The companies plan to submit the data to regulatory authorities for emergency use authorization.
• In June 2021, Roche announced that it had received FDA approval for its intravitreal implant, which is used to treat neovascular (wet) age-related macular degeneration. The implant delivers a sustained release of the drug ranibizumab, reducing the need for frequent injections.

Drug & Gene Delivery Systems Market: Report Scope

Drug & Gene Delivery Systems Market: Regional Analysis

North America region to dominate the global market during the forecast period

Based on region, the North American region held the largest drug and gene delivery systems market share in 2022 and is further predicted to grow at a notable CAGR during the forecast period. The global drug and gene delivery systems market has been growing steadily, with North America being a significant contributor to this growth. The market is driven by factors such as the increasing prevalence of chronic diseases, the aging population, and a growing demand for personalized and targeted therapies. The pharmaceutical and biotechnology industries in North America are among the largest in the world, and this has resulted in significant investment in research and development of new drug and gene delivery technologies. Furthermore, the region has a well-established regulatory framework, which has helped to streamline the development and approval process for new drugs and gene therapies.

Request Free Sample

In addition, the oral segment of the market has been experiencing strong growth in North America, with the development of new oral delivery technologies and the growing demand for patient-centric healthcare. With ongoing advancements in drug and gene delivery technologies and a continued focus on improving patient outcomes, the global drug and gene delivery systems market is expected to continue its growth trajectory in North America and across the globe.

Drug & Gene Delivery Systems Market: Competitive Players

The major players in the global drug & gene delivery systems market include:

• Pfizer
• Johnson & Johnson
• Novartis
• Roche
• Merck & Co.
• Sanofi
• GlaxoSmithKline
• AbbVie
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Celgene
• Amgen
• Biogen
• Gilead Sciences
• Illumina
• Regeneron Pharmaceuticals
• Vertex Pharmaceuticals
• Moderna
• CRISPR Therapeutics
• Among Others.

The report segment of global drug & gene delivery systems market is as follows:

By Delivery System

• Drug Delivery Systems
• Gene Delivery Systems

By Route of Administration

• Oral
• Ocular
• Nasal
• Injectable
• Inhalation
• Transdermal
• Topical

By Application

• Diabetes
• CNS
• Infectious Diseases
• Oncology
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa